Latest filing published 30 Jun 2026 for HLS Therapeutics Inc., €26k.
No signal scores available.
This profile gathers the share dealings of David Andrew Spence in HLS Therapeutics Inc. The record holds 2 filings, for trades running from 17 March 2021 to 26 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 30 June 2026: a share grant of €26k, in HLS Therapeutics Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations